Deep search
Search
Images
Copilot
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Jamie Dimon, JPMorgan Chase
JPMorgan Chase is boosting buybacks even after CEO Jamie Dimon called the stock expensive
Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was excess capital.
JP Morgan Chase's Jamie Dimon plans to stick around 'for a few more years' as CEO
JPMorgan Chase & Co.'s Chief Executive Jamie Dimon told analysts on Wednesday he plans to stay in the job "for a few more years." That would mean that Dimon, who will be 69 in March, would stay at the helm of the U.
Jamie Dimon addresses a fresh round of CEO succession questions in an earnings call
Jamie Dimon said there is a running list of executives who could replace him as CEO of JPMorgan. The comments follow the latest leadership reshuffle.
Jamie Dimon's 'base case' for stepping down as JPMorgan CEO is a few years from now
Jamie Dimon agreed Wednesday with an analyst's assessment that his "base case" for stepping down as JPMorgan Chase CEO is a few years from now.
JPMorgan Chase's Jamie Dimon praises 'resilient economy' but he's wary about inflation and geopolitics
JPMorgan Chase & Co.'s Chief Executive Jamie Dimon said the U.S. economy remains "resilient" but he remains wary of inflation and uncertain geopolitics. "Unemployment remains relatively low, and consumer spending stayed healthy,
JPMorgan CEO Dimon says succession path is up to board, ‘not just about me’
He expects to “stay around for a few more years.” Says board reviews successor candidates regularly.Stay Ahead of the Market:Discover
JPMorgan Chase's Q4 Results Top Estimates
JPMorgan Chase and Goldman Sachs Post Surging Profits
Big bank profits surged in the fourth quarter and Wall Street roared back to life, with net income rising 50% at JPMorgan Chase and more than doubling at Goldman Sachs.
JPMorgan Chase's Q4 Results Top Estimates as Investment Banking Fees Surge
JPMorgan Chase reported fourth-quarter results Wednesday that came in above analysts' expectations as investment banking fees rose.
JPMorgan Chase posts record profit as the bank’s massive scale pays off
JPMorgan Chase reported fourth-quarter earnings before the opening bell Wednesday. Here's what the company reported compared with what Wall Street analysts surveyed by LSEG were expecting: Earnings: $4.
3d
on MSN
JPMorgan Chase disables internal comments after employees rip return-to-office policy
JPMorgan Chase management disabled comments on an internal webpage where the policy was announced, according to the Wall ...
14h
5 Insights From The 2025 JP Morgan Healthcare Conference
The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...
1d
JPMorgan Chase (JPM) Q4 2024 Earnings Call Transcript
JPMorgan Chase (NYSE: JPM) Q4 2024 Earnings Call Jan 15, 2025, 8:30 a.m. ET Good morning, ladies and gentlemen. Welcome to ...
9d
on MSN
JPMorgan Chase to order staffers back to office 5 days a week: report
The bank – the largest in the US with more than 300,000 employees worldwide – is expected to announce the change in the next ...
GlobalData on MSN
17h
JP Morgan 2025: GoodRx takes aim at US drug pricing challenges
GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.
9h
JP Morgan 2025: Radiopharmaceuticals M&A fuels Telix’s busy year
The radiopharmaceutical developer expanded its reach, acquiring R&D, isotope production, manufacturing, and distribution.
18h
JPMorgan Chase & Co.: Hold Rating Maintained Amid Positive Earnings and Future Uncertainties
Betsy Graseck, an analyst from Morgan Stanley, maintained the Hold rating on JPMorgan Chase & Co. (JPM – Research Report). The associated ...
GlobalData on MSN
1d
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Goldman Sachs
Jamie Dimon
Daniel Pinto
Jennifer Piepszak
Investment banking
Feedback